Approval · Notice of Compliance 7121 · 2005

ZOCOR: Notice of Compliance 7121

Issued June 22, 2005

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7121
Date: June 22, 2005
Company: Merck Frosst Canada Ltd., Merck Frosst Canada Ltée
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Lipid metabolism regulator

Products in this notice

Brand	DIN	Status today
ZOCOR	00884324	Cancelled Post Market
ZOCOR	00884332	Marketed
ZOCOR	00884340	Marketed
ZOCOR	00884359	Marketed
ZOCOR	02240332	Cancelled Post Market

Medicinal ingredients

SIMVASTATIN 5 MG per TAB
SIMVASTATIN 10 MG per TAB
SIMVASTATIN 20 MG per TAB
SIMVASTATIN 40 MG per TAB
SIMVASTATIN 80 MG per TAB